What's a sensible re-entry point do you think? FPH a great company just chronically over priced. Still 9% of my remaining portfolio.
Printable View
It would have to more than halve before it would be worth casting an eye to it.
its EPS is 40.5 cents per share.
for a company currently $20 per share. Let that sink in.
Share price was cycling between about $12 and $16.50 from late 2017 into early 2019 (looks like an average of around $14 through that time), so if we're just giving up a years worth of gains that would suggest that anything under $15 is probably pretty good and under $14 even better.
You are just one of many dreamers on the threads imo, scroll back and look.
Meanwhile as the USA and other countries become enveloped with Covid 19,F&P is very well placed to help.
"This result was mainly driven by our Hospital product group, which delivered revenue growth of 19 per cent. We saw strong demand for our Optiflow and AIRVO systems, which continued to benefit from the growing body of clinical research in the use of nasal high flow therapy. Our results were also assisted by the extended flu season in the United States.
View report
Scroll back and you will see it always has been;) Im up 652% atm
"This result was mainly driven by our Hospital product group, which delivered revenue growth of 19 per cent. We saw strong demand for our Optiflow and AIRVO systems, which continued to benefit from the growing body of clinical research in the use of nasal high flow therapy. Our results were also assisted by the extended flu season in the United States
Hang in there biscuit it may well come to you with this carnage/meltdown anything can happen
"Our results were also assisted by the extended flu season in the United States"